-- Alan Mozes
TUESDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer
may be twice as likely to have started showing signs of male
pattern baldness at the age of 20 than those without prostate
cancer, a new French study suggests.
Men who start losing their hair in their 30s or 40s do not
appear to face a similar boost in prostate cancer risk. And those
whose hair loss starts in their 20s do not face a higher risk of
developing the cancer at an early age or of developing more
aggressive tumors, the research team noted.
Whether or not men who experience youthful hair loss may benefit
from prostate cancer screening is yet to be determined, the study
"At present, there is no hard evidence to show any benefit from screening the general population for prostate cancer," study author Dr. Philippe Giraud, from the European Georges Pompidou Hospital in Paris, said in a news release from the European Society for Medical Oncology. "We need a way of identifying those men who are at high risk of developing the disease."
Noting that androgens associated with hair loss are also
associated with prostate cancer, he and the other researchers
called for more studies to see whether interventions might be
appropriate for men with very early balding.
Physicians need to know "who could be targeted for screening and
also considered for chemo-prevention using anti-androgenic drugs
such as finasteride," Giraud said.
"Balding at the age of 20 may be one of these easily identifiable risk factors, and more work needs to be done now to confirm this," he added.
Giraud, who is also a professor of radiation oncology at the
Paris Descartes University, reports his team's findings in the Feb.
15 online edition of the journal
Annals of Oncology.
The authors noted that male pattern baldness (androgenic
alopecia) is very common, affecting about half of all men at some
point in their lives.
Its onset has previously been linked to the conversion of
testosterone to androgenic hormones, and androgens have also been
previously implicated in the onset and growth of prostate
The drug finasteride -- used to treat baldness -- blocks the
conversion of testosterone to an androgen thought to cause hair
loss, and the drug has also been demonstrated to lower the
incidence of prostate cancer.
To explore the possible connection between balding patterns and
prostate cancer, the research team spent more than two years
analyzing disease progression and hair loss patterns in 388 men
with prostate cancer.
The men were diagnosed between the ages of 46 and 84. Starting
in 2004, the investigators asked them to indicate whether or not
they had experienced any previous balding, when their hair loss
began, and specifically what type of hair loss had occurred at 20,
30 and 40.
Another 281 healthy men were enlisted in the study for
The research team found that 37 of the prostate cancer patients
(and 14 of the healthy men) had experienced some form of hair loss
at the age of 20, ranging from a receding hairline to a bald patch
at the top of the head, or a combination of both.
Any form of hair loss at age 20 was linked to a doubling of
prostate cancer risk, the study authors reported, with no specific
pattern of hair loss being more predictive of risk than any
The research team cautioned, however, that it is premature to
conclude that baldness and prostate cancer are, in fact,
For his part, Dr. Nelson Neal Stone, a clinical professor of
urology and radiation oncology at Mount Sinai School of Medicine in
New York City, agreed that while "the study is food for thought,"
it is in no way conclusive.
"First of all, the number of patients involved is very low, which makes interpretation and application to the general population very risky," he said.
"But we do know that there are genetic factors that make prostate cancer more prevalent," Stone said. "For example, men who have a first-degree relative -- an uncle, father or brother -- who have a diagnosis of prostate cancer are 2.5 to three times more likely to develop prostate cancer themselves than men who don't have such a history. And genetics also plays a role in men who develop early hair loss."
"So, you have two genetically related factors that there may be an association from, and each may be linked to early high male hormone levels. So it may be a hormonally related situation," Stone acknowledged. "But it's very hard to prove."
For more on prostate cancer risk, visit the
American Cancer Society.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.